Captopren AG may be available in the countries listed below.
Ingredient matches for Captopren AG
Captopril is reported as an ingredient of Captopren AG in the following countries:
- Peru
International Drug Name Search
Captopren AG may be available in the countries listed below.
Captopril is reported as an ingredient of Captopren AG in the following countries:
International Drug Name Search
Biteral may be available in the countries listed below.
Ornidazole is reported as an ingredient of Biteral in the following countries:
International Drug Name Search
Diastop may be available in the countries listed below.
Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Diastop in the following countries:
Diphenoxylate hydrochloride (a derivative of Diphenoxylate) is reported as an ingredient of Diastop in the following countries:
International Drug Name Search
Topisolone may be available in the countries listed below.
Desoximetasone is reported as an ingredient of Topisolone in the following countries:
International Drug Name Search
Generic Name: bosentan (boe SEN tan)
Brand Names: Tracleer
Bosentan prevents thickening of the blood vessels, especially those in the lungs and heart. Bosentan also lowers blood pressure in your lungs, helping your heart pump blood more efficiently.
Bosentan is used to treat pulmonary arterial hypertension (PAH). It improves your ability to exercise and prevents your condition from getting worse.
Bosentan may also be used for other purposes not listed in this medication guide.
Your doctor may have you take a pregnancy test before you start using this medicine, to make sure you are not pregnant. You may also be re-tested each month during your treatment.
are also taking HIV/AIDS medication that contains lopinavir or ritonavir (Kaletra, Norvir);
are also taking using glyburide (Micronase, DiaBeta, Glynase Pres Tab);
are pregnant or might become pregnant during treatment; or
are also using cyclosporine (Sandimmune, Neoral, Gengraf).
Your doctor may have you take a pregnancy test before you start using this medicine, to make sure you are not pregnant. You may also be re-tested each month during your treatment.
Take bosentan exactly as it was prescribed for you. Do not take the medication in larger or smaller amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.
Bosentan can be taken with or without food.
Bosentan is usually taken twice a day, morning and evening.
See also: Bosentan dosage (in more detail)
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.
Overdose can cause headache, nausea, vomiting, increased heart rate and fainting or dizziness (low blood pressure).
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using bosentan.
nausea, stomach pain, loss of appetite;
dark urine, clay-colored stools; or
jaundice (yellowing of the skin or eyes).
Less serious side effects may include:
headache;
flushing;
swelling of the feet, ankles, or legs;
dizziness;
upset stomach;
fatigue; or
itching.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Pulmonary Hypertension:
greater than or equal to 40 kg:
Initial dose: 62.5 mg twice daily for 4 weeks
Maintenance dose: increase to a maintenance dose of 125 mg twice daily
less than 40 kg:
Initial dose: 62.5 mg twice daily for 4 weeks
Maintenance dose: continue dosing of 62.5 mg twice daily
Usual Pediatric Dose for Pulmonary Hypertension:
Full Term Neonate: Oral: 1 mg/kg/dose orally twice daily short-term use (2 to 16 days) in three full term neonates has been reported. In the initial report, two full term neonates (8 days and 14 days old) with persistent pulmonary hypertension of the newborn (PPHN) and transposition of the great arteries received bosentan prior to cardiac surgery; patients also received other therapies. A case report describes the use of bosentan monotherapy for PPHN in a full term neonate as primary course of treatment initiated at 29 hours of life; therapy was weaned after 72 hours through the following dose reductions: 0.5 mg/kg/dose orally twice daily followed by 0.5 mg/kg once daily and subsequent discontinuation at 96 hours of treatment.
1 month to 12 years:
less than 10 kg: Initial: 1 to 2 mg/kg orally twice daily for 4 weeks; increase to maintenance dose of 2 to 4 mg/kg orally twice daily.
10 to 20 kg: Initial: 31.25 mg orally daily for 4 weeks; increase to maintenance dose of 31.25 mg orally twice daily.
over 20 to 40 kg: Initial: 31.25 mg orally twice daily for 4 weeks; increase to maintenance dose of 62.5 mg orally twice daily.
over 40 kg: Initial: 62.5 mg orally twice daily for 4 weeks; increase to maintenance dose of 125 mg orally twice daily.
over 12 years:
less than 40 kg: 62.5 mg orally twice daily.
40 kg or more: 62.5 mg orally twice daily for 4 weeks; increase to maintenance dose of 125 mg twice daily.
amiodarone (Cordarone, Pacerone);
diltiazem (Tiazac, Cartia, Cardizem);
erythromycin (E.E.S., EryPed, Ery-Tab, Erythrocin);
rifampin (Rifadin, Rifater, Rifamate, Rimactane);
tacrolimus (Prograf);
an antifungal medication such as ketoconazole (Nizoral), fluconazole (Diflucan), or itraconazole (Sporanox);
a blood thinner such as warfarin (Coumadin); or
a cholesterol-lowering medicine such as simvastatin (Zocor), lovastatin (Mevacor), or atorvastatin (Lipitor).
This list is not complete and there may be other drugs not listed that can affect bosentan. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
See also: bosentan side effects (in more detail)
Ranitidina Lazar may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidina Lazar in the following countries:
International Drug Name Search
Enalapril + Idroclorotiazide AWP may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril + Idroclorotiazide AWP in the following countries:
Hydrochlorothiazide is reported as an ingredient of Enalapril + Idroclorotiazide AWP in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Abamectin is reported as an ingredient of Virbamec in the following countries:
Clorsulon is reported as an ingredient of Virbamec in the following countries:
Ivermectin is reported as an ingredient of Virbamec in the following countries:
International Drug Name Search
Cordamil may be available in the countries listed below.
Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Cordamil in the following countries:
International Drug Name Search
Kélocyanor may be available in the countries listed below.
Edetic Acid dicobalt salt (a derivative of Edetic Acid) is reported as an ingredient of Kélocyanor in the following countries:
International Drug Name Search
Retrieve may be available in the countries listed below.
Tretinoin is reported as an ingredient of Retrieve in the following countries:
International Drug Name Search